Amrize Ltd (AMRZ)vsLinde plc Ordinary Shares (LIN)
AMRZ
Amrize Ltd
$53.78
-5.27%
BASIC MATERIALS · Cap: $31.81B
LIN
Linde plc Ordinary Shares
$501.14
-0.71%
BASIC MATERIALS · Cap: $232.23B
Smart Verdict
WallStSmart Research — data-driven comparison
Linde plc Ordinary Shares generates 188% more annual revenue ($33.99B vs $11.81B). LIN leads profitability with a 20.3% profit margin vs 10.0%. AMRZ appears more attractively valued with a PEG of 1.53. LIN earns a higher WallStSmart Score of 56/100 (C).
AMRZ
Buy53
out of 100
Grade: C-
LIN
Buy56
out of 100
Grade: C
Intrinsic Value Comparison
Multi-model valuation · Graham Formula
Margin of Safety
-7.0%
Fair Value
$55.08
Current Price
$53.78
$1.30 premium
Margin of Safety
-44.6%
Fair Value
$346.56
Current Price
$501.14
$154.58 premium
Key Strengths & Concerns
Side-by-side fundamental analysis
Key Strengths
Reasonable price relative to book value
Generating 1.6B in free cash flow
Mega-cap, among the largest globally
Keeps 20 of every $100 in revenue as profit
Strong operational efficiency at 28.2%
Generating 1.6B in free cash flow
Areas to Watch
Expensive relative to growth rate
Moderate valuation
3.6% earnings growth
Weak financial health signals
Expensive relative to growth rate
Premium valuation, high expectations priced in
Weak financial health signals
Earnings declined 9.4%
Comparative Analysis Report
WallStSmart ResearchBull Case : AMRZ
The strongest argument for AMRZ centers on Price/Book, Free Cash Flow.
Bull Case : LIN
The strongest argument for LIN centers on Market Cap, Profit Margin, Operating Margin. Profitability is solid with margins at 20.3% and operating margin at 28.2%.
Bear Case : AMRZ
The primary concerns for AMRZ are PEG Ratio, P/E Ratio, EPS Growth.
Bear Case : LIN
The primary concerns for LIN are PEG Ratio, P/E Ratio, Piotroski F-Score.
Key Dynamics to Monitor
AMRZ profiles as a value stock while LIN is a mature play — different risk/reward profiles.
LIN is growing revenue faster at 5.8% — sustainability is the question.
AMRZ generates stronger free cash flow (1.6B), providing more financial flexibility.
Monitor BUILDING MATERIALS industry trends, competitive dynamics, and regulatory changes.
Bottom Line
LIN scores higher overall (56/100 vs 53/100), backed by strong 20.3% margins. Both earn "Buy" and "Buy" ratings respectively — the choice depends on your investment horizon and risk tolerance.
This analysis is generated from publicly available financial data. Not financial advice.
Amrize Ltd
BASIC MATERIALS · BUILDING MATERIALS · USA
Amrize Ltd (AMRZ) is a cutting-edge technology firm revolutionizing the digital health and wellness sector by leveraging advanced technologies and data-driven solutions to enhance healthcare delivery. Focused on improving patient outcomes and expanding healthcare accessibility, Amrize is committed to extensive research and development that caters to the escalating demand for scalable health innovations. Its strategic initiatives and robust product offerings position the company as a significant contributor to the transformation of modern healthcare systems, making it a compelling investment opportunity in an evolving market landscape.
Visit Website →Linde plc Ordinary Shares
BASIC MATERIALS · SPECIALTY CHEMICALS · USA
Linde plc is a multinational chemical company. It is the largest industrial gas company by market share and revenue. It serves customers in the healthcare, petroleum refining, manufacturing, food, beverage carbonation, fiber-optics, steel making, aerospace, chemicals, electronics and water treatment industries. The company's primary business is the manufacturing and distribution of atmospheric gases, including oxygen, nitrogen, argon, rare gases, and process gases, including carbon dioxide, helium, hydrogen, electronic gases, specialty gases, and acetylene.
Visit Website →Compare with Other BUILDING MATERIALS Stocks
Want to dig deeper into these stocks?